Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer

PURPOSE: Triple negative breast cancers (TNBC) frequently have high epidermal growth factor receptor (EGFR) expression and are sensitive to DNA-damaging agents. Improved therapies are needed for this aggressive malignancy. PATIENTS AND METHODS: We performed a phase I trial of bendamustine and erloti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Layman, Rachel M., Ruppert, Amy S., Lynn, Melinda, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Lustberg, Maryam B., Wesolowski, Robert, Ottman, Susan, Carothers, Sarah, Bingman, Anissa, Reinbolt, Raquel, Kraut, Eric H., Shapiro, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3710373/
https://ncbi.nlm.nih.gov/pubmed/23430121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2112-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares